Drugs / MRX-7EAT
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01198834 | Sep 2010 → Jun 2011 | — | MEDRx USA, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01161615 | Jul 2010 → Jun 2011 | bursitis, tendinitis | MEDRx USA, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MRX-7EAT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01161615 ↗ |
| Route | Topical | “Etodolac-Lidocaine Topical Patch” NCT01161615 ↗ |